Rezolute, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Stock-Based Compensation (Tables)

Stock-Based Compensation (Tables)

9 Months Ended

12 Months Ended

Mar. 31, 2015

Jun. 30, 2014

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

AntriaBio has computed the fair value of all options granted during the year ended June 30, 2014 using the following assumptions:

Expected volatility	94	%
Risk free interest rate	2.16% - 2.26	%
Expected term (years)	7
Dividend yield	0	%

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

Stock option activity is as follows:

			Weighted		Weighted Average
	Number of		Average		Remaining
	Options		Exercise Price		Contractual Life
Outstanding, June 30, 2013		1,508,334	$	4.50		4.6
Granted		2,835,000	$	3.14
Outstanding, June 30, 2014		4,343,334	$	3.61		5.6
Granted		4,532,000	$	2.03
Forfeited		(212,916)	$	3.57
Outstanding, March 31, 2015		8,662,418	$	2.78		7.4

Exercisable at March 31, 2015		2,065,147	$	3.95		4.1

Stock option activity is as follows:

		Weighted		Weighted Average
	Number of	Average		Remaining
	Options	Exercise Price		Contractual Life
Outstanding, June 30, 2012	-	$	-	-
Granted	1,508,334	$	4.50
Outstanding, June 30, 2013	1,508,334	$	4.50	4.6
Granted	2,835,000	$	3.14
Outstanding, June 30, 2014	4,343,334	$	3.61	5.6

Exercisable at June 30, 2014	1,387,871	$	4.33	4.0

Schedule Of Warrants Issued To Agents Activity [Table Text Block]

AntriaBio issued warrants to agents and note holders in conjunction with the closing of its convertible notes payable and equity financings as follows:

			Weighted		Weighted Average
	Number of		Average		Remaining
	Warrants		Exercise Price		Contractual Life
Outstanding, June 30, 2013		293,092	$	2.21		4.1
Warrants issued to note holders		225,259	$	1.89
Warrants issued to note holders		4,039,184	$	1.98
Warrants issued to related party		39,117	$	7.50
Warrants issued in private placement		6,287,679	$	2.34
Warrants issued to placement agent		290,861	$	1.56
Warrants issued for investor relations		66,667	$	3.34
Warrants exercised		(100,550)	$	1.17
Warrants forfeited		(41,570)	$	1.17
Outstanding, June 30, 2014		11,099,739	$	2.21		3.6
Warrants issued in private placements		5,276,280	$	2.50
Warrants issued to placement agent		1,576,937	$	2.50
Warrants issued for investor relations		105,000	$	1.65
Warrants cancelled		(59,758)	$	2.92
Outstanding, March 31, 2015		17,998,198	$	2.31		3.0

Warrants- AntriaBio issued warrants to agents in conjunction with the closing of various financings and issued warrants in note conversions and private placements as follows:

		Weighted		Weighted Average
	Number of	Average		Remaining
	Warrants	Exercise Price		Contractual Life
Outstanding, June 30, 2012	-	$	-	-
Warrants issued to placement agents	41,424	$	2.03
Warrants issued to placement agent	233,334	$	2.03
Warrants issued to placement agent	18,334	$	4.95
Outstanding, June 30, 2013	293,092	$	2.21	4.1
Warrants issued to note holders	225,259	$	1.89
Warrants issued to note holders	4,039,184	$	1.98
Warrants issued to related party	39,117	$	7.50
Warrants issued in private placement	6,287,679	$	2.34
Warrants issued to placement agent	290,861	$	1.56
Warrants issued for invest or relations	66,667	$	3.34
Warrants exercised	(100,550)	$	1.17
Warrants forfeited	(41,570)	$	1.17
Outstanding, June 30, 2014	11,099,739	$	2.21	3.6

Black Scholes Pricing Model

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

AntriaBio has computed the fair value of all options granted during the nine months ended March 31, 2015 using the following assumptions:

Expected volatility	90 - 92	%
Risk free interest rate	1.31% - 1.88	%
Expected term (years)	5 - 7
Dividend yield	0	%

Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block]

The estimated fair value was derived using the lattice model with the following assumptions:

Expected volatility	93	%
Risk free interest rate	2.21	%
Warrant term (years)	7
Dividend yield	0	%

Significant assumptions were as follows:

Expected volatility	92% - 97	%
Risk free interest rate	0.78% - 2.21	%
Contractual term (years)	3 - 7
Dividend yield	0	%

Lattice Model

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block]

The estimated fair value was derived using the lattice model with the following assumptions:

Expected volatility	93	%
Risk free interest rate	2.21	%
Contractual term (years)	7
Dividend yield	0	%

Lattice Model One

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block]

The estimated fair value was derived using the lattice model with the following assumptions:

Expected volatility	90% - 91	%
Risk free interest rate	1.89% - 1.98	%
Warrant term (years)	7
Dividend yield	0	%

Lattice Model Two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule Of Share Based Payment Award Stock Warrants Valuation Assumptions [Table Text Block]

The estimated fair value was derived using the lattice model with the following assumptions:

Expected volatility	90	%
Risk free interest rate	1.71	%
Warrant term (years)	7
Dividend yield	0	%

Black Scholes Valuation Model

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The Black-Scholes valuation methodology was used because that model embodies all of the relevant assumptions that address the features underlying these instruments. Significant assumptions were as follows:

Expected volatility	89% - 97	%
Risk free interest rate	0.56% - 2.21	%
Warrant term (years)	2 - 7
Dividend yield	0	%